SETDB1 and cancer: Although the findings of studies on SETDB1 have consistently indicated its oncogenic role in various cancers, the broad ranges of genomic targets and protein partners of SETDB1 (usually, transcription factors and associated epidrivers), along with their global effects, make it challenging to prove an immediate connection of SETDB1 with certain tumors.